Skip to main navigation Skip to search Skip to main content

Peptide mimetic compounds can activate or inhibit cardiac and skeletal ryanodine receptors

Ken Robinson, Dane Culley, Sam Waring, Graham D. Lamb, Christopher Easton, Marco G. Casarotto, Angela F. Dulhunty*

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    3 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Peptide mimetic compounds can activate or inhibit cardiac and skeletal ryanodine receptors'. Together they form a unique fingerprint.
    Sort by

    Biochemistry, Genetics and Molecular Biology